Early recurrence of atrial tachyarrhythmia after catheter ablation and its associations with clinical outcomes, atrial fibrillation burden, and blanking period duration: a post hoc analysis of the CABANA trial
Europace · 2026
DOI: 10.1093/europace/euag173 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Europace, 2026. Verfasst von Hongyu Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The Second Affiliated Hospital, School of Basic Sciences, Jiangxi Medical College, Nanchang University, Nancha…. Hauptthemen laut MEDLINE: Catheter Ablation, Atrial Fibrillation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC), NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Aims
Early recurrence of atrial tachyarrhythmia (ERAT) after catheter ablation for atrial fibrillation (AF) is common, yet its prognostic significance and implications for the duration of the blanking period remain uncertain. We aimed to evaluate the association between ERAT and post-ablation clinical outcomes, late arrhythmia recurrence, and AF burden, and to explore the optimal duration of the blanking period. Methods and results This post hoc analysis included 811 patients from the CABANA trial who underwent catheter ablation and had trial-specific electrocardiographic monitoring data available. ERAT was defined as any episode of AF, atrial flutter, or atrial tachycardia lasting >30 s within the 90-day blanking period. The primary outcome was a composite of all-cause mortality, disabling stroke, serious bleeding, or cardiac arrest. Secondary outcomes included cardiovascular hospitalization and late atrial tachyarrhythmia recurrence. During a median 4 years (IQR 2.5–5.2) follow-up, ERAT occurred in 567 patients (69.9%). Patients with ERAT had higher risks of cardiovascular hospitalization [adjusted hazard ratio (aHR) 1.35, 95% confidence interval (CI) 1.07–1.71] and of the composite outcome of all-cause mortality or cardiovascular hospitalization (aHR 1.33, 95% CI 1.07–1.66), but no increased risk of the primary composite outcome. ERAT was independently associated with late atrial tachyarrhythmia recurrence (aHR 1.35, 95% CI 1.07–1.71). Prognostic relevance varied by timing, with the strongest association observed for ERAT occurring between 60 and 90 days after ablation (aHR 1.80, 95% CI 1.16–2.79). Receiver operating characteristic analysis identified 58 days as the optimal threshold for predicting late arrhythmia recurrence (AUC 0.727).
Conclusion
ERAT was associated with higher risks of cardiovascular hospitalization and late atrial tachyarrhythmia recurrence in a time-dependent manner, supporting a shorter blanking period to better identify patients at risk of adverse rhythm outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The Second Affiliated Hospital, School of Basic Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, People's Republic of China.
- Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, William Henry Duncan Building, 6 West Derby Street, Liverpool L7 8TX, UK.
- Department of Cardiovascular Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, People's Republic of China.
- Department of Computer Science, Faculty of Environment, Science and Economy, University of Exeter, Exeter, UK.
- Department of Hematology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
- Internal, Vascular and Emergency Medicine-Stroke Unit, University of Perugia, Perugia, Italy.
ORCID-Profile: Hongyu Liu, Wenhui Li, Eva Soler-Espejo, Tommaso Bucci, Yang Liu, Manlin Zhao, Bi Huang, Dhiraj Gupta, Yang Chen, Gregory Y H Lip
Förderung
- Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC)
- NIH HHS
- National Institutes of Health
Zitieren
APA
Liu, H., Hu, R., Li, W., Soler-Espejo, E., Bucci, T., Liu, Y., Zhao, M., Gu, T., Fan, W., Huang, B., Gupta, D., Packer, D. L., Chen, Y., & Lip, G. Y. H. (2026). Early recurrence of atrial tachyarrhythmia after catheter ablation and its associations with clinical outcomes, atrial fibrillation burden, and blanking period duration: a post hoc analysis of the CABANA trial. Europace. https://doi.org/10.1093/europace/euag173
Vancouver
Liu H, Hu R, Li W, Soler-Espejo E, Bucci T, Liu Y, et al. Early recurrence of atrial tachyarrhythmia after catheter ablation and its associations with clinical outcomes, atrial fibrillation burden, and blanking period duration: a post hoc analysis of the CABANA trial. Europace. 2026. doi:10.1093/europace/euag173
BibTeX
@article{Liu2026,
author = {Liu, Hongyu and Hu, Runhui and Li, Wenhui and Soler-Espejo, Eva and Bucci, Tommaso and Liu, Yang and Zhao, Manlin and Gu, Tianshu and Fan, Weiguo and Huang, Bi and Gupta, Dhiraj and Packer, Douglas L and Chen, Yang and Lip, Gregory Y H},
title = {Early recurrence of atrial tachyarrhythmia after catheter ablation and its associations with clinical outcomes, atrial fibrillation burden, and blanking period duration: a post hoc analysis of the CABANA trial},
journal = {Europace},
year = {2026},
doi = {10.1093/europace/euag173}
}
EUVIMED